Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.

Congestive heart failure (Greenwich, Conn.)

Volumn 11, Issue 2, 2005, Pages 59-64

  Abraham, William T ^a   Cheng, Mei L ^a   Smoluk, Geraldine ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; GLYCERYL TRINITRATE; NATRIURETIC FACTOR; VASODILATOR AGENT;

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG WEDGE PRESSURE; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SAFETY; TIME; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; NITROGLYCERIN; PULMONARY WEDGE PRESSURE; SAFETY; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 23044438040     PISSN: 15275299     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2005.03792.x     Document Type: Article

References (0)